1. Home
  2. CCCC

CCCC

C4 Therapeutics Inc.

Logo C4 Therapeutics Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.

Founded: 2015 Country:
United States
United States
Employees: N/A City: WATERTOWN
Market Cap: 525.5M IPO Year: 2020
Target Price: $8.86 AVG Volume (30 days): 2.9M
Analyst Decision: Buy Number of Analysts: 7
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -2.67 EPS Growth: N/A
52 Week Low/High: $1.06 - $11.88 Next Earning Date: 05-02-2024
Revenue: $20,756,000 Revenue Growth: -33.25%
Revenue Growth (this year): 31.87% Revenue Growth (next year): -20.06%

Share on Social Networks: